Diet-induced Obesity in C57BL/6J Mice Causes Increased Renal Lipid Accumulation and Glomerulosclerosis via a Sterol Regulatory Element-binding Protein-1c-dependent Pathway*

Obesity and metabolic syndrome are associated with glomerulosclerosis and proteinuria, but the mechanisms are not known. The purpose of this study was to determine if there is altered renal lipid metabolism and increased expression of sterol regulatory element-binding proteins (SREBPs) in a model of diet-induced obesity. C57BL/6J mice that were fed a high fat, 60 kcal % saturated (lard) fat diet (HFD) developed obesity, hyperglycemia, and hyperinsulinemia compared with those that were fed a low fat, 10 kcal % fat diet (LFD). In contrast, A/J mice were resistant when fed the same diet. C57BL/6J mice with HFD exhibited significantly higher levels of renal SREBP-1 and SREBP-2 expression than those mice with LFD, whereas in A/J mice there were no changes with the same treatment. The increases in SREBP-1 and SREBP-2 expression in C57BL/6J mice resulted in renal accumulation of triglyceride and cholesterol. There were also significant increases in the renal expression of plasminogen activator inhibitor-1 (PAI-1), vascular endothelial growth factor (VEGF), type IV collagen, and fibronectin, resulting in glomerulosclerosis and proteinuria. To determine a role for SREBPs per se in modulating renal lipid metabolism and glomerulosclerosis we performed studies in SREBP-1c–/– mice. In contrast to control mice, in the SREBP-1c–/– mice with HFD the accumulation of triglyceride was prevented, as well as the increases in PAI-1, VEGF, type IV collagen, and fibronectin expression. Our results therefore suggest that diet-induced obesity causes increased renal lipid accumulation and glomerulosclerosis in C57BL/6J mice via an SREBP-1c-dependent pathway.

[1]  Shuiqing Yu,et al.  Diabetes Induces Endothelial Dysfunction but Does Not Increase Neointimal Formation in High-Fat Diet Fed C57BL/6J Mice , 2005, Circulation research.

[2]  C. Kahn,et al.  Effects of diet and genetic background on sterol regulatory element-binding protein-1c, stearoyl-CoA desaturase 1, and the development of the metabolic syndrome. , 2005, Diabetes.

[3]  Christoph Handschin,et al.  Hyperlipidemic Effects of Dietary Saturated Fats Mediated through PGC-1β Coactivation of SREBP , 2005, Cell.

[4]  W. Katon,et al.  Racial and ethnic differences in microalbuminuria prevalence in a diabetes population: the pathways study. , 2004, Journal of the American Society of Nephrology : JASN.

[5]  B. Wisse,et al.  The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. , 2004, Journal of the American Society of Nephrology : JASN.

[6]  Y. Guan Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome. , 2004, Journal of the American Society of Nephrology : JASN.

[7]  C. Abrass Overview: obesity: what does it have to do with kidney disease? , 2004, Journal of the American Society of Nephrology : JASN.

[8]  Samy I McFarlane,et al.  The relationship between hyperinsulinemia, hypertension and progressive renal disease. , 2004, Journal of the American Society of Nephrology : JASN.

[9]  S. Bagby Obesity-initiated metabolic syndrome and the kidney: a recipe for chronic kidney disease? , 2004, Journal of the American Society of Nephrology : JASN.

[10]  C. Alpers,et al.  Original Report: Laboratory Investigation Hyperglycemia and Hyperlipidemia Act Synergistically to Induce Renal Disease in Ldl Receptor-deficient Balb Mice , 2022 .

[11]  R. Hammer,et al.  Overexpression of Sterol Regulatory Element-binding Protein-1a in Mouse Adipose Tissue Produces Adipocyte Hypertrophy, Increased Fatty Acid Secretion, and Fatty Liver* , 2003, Journal of Biological Chemistry.

[12]  H. Vidal,et al.  Intramyocitic lipid accumulation and SREBP-1c expression are related to insulin resistance and cardiovascular risk in morbid obesity. , 2003, Atherosclerosis.

[13]  R. B. Rawson The SREBP pathway — insights from insigs and insects , 2003, Nature Reviews Molecular Cell Biology.

[14]  M. Simionescu,et al.  Saturated-fat diet induces moderate diabetes and severe glomerulosclerosis in hamsters , 2003, Diabetologia.

[15]  R. Bigazzi,et al.  A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  Jukka T Salonen,et al.  The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. , 2002, JAMA.

[17]  J. Xu,et al.  Dietary polyunsaturated fats regulate rat liver sterol regulatory element binding proteins-1 and -2 in three distinct stages and by different mechanisms. , 2002, The Journal of nutrition.

[18]  C. Trautwein,et al.  Insulin and Sterol-regulatory Element-binding Protein-1c (SREBP-1C) Regulation of Gene Expression in 3T3-L1 Adipocytes , 2002, The Journal of Biological Chemistry.

[19]  M. Praga Obesity--a neglected culprit in renal disease. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  C. Marcantoni,et al.  Hypertensive nephrosclerosis in African Americans versus Caucasians. , 2002, Kidney international.

[21]  H. Shimano,et al.  Absence of Sterol Regulatory Element-binding Protein-1 (SREBP-1) Ameliorates Fatty Livers but Not Obesity or Insulin Resistance inLep ob /Lep ob Mice* , 2002, The Journal of Biological Chemistry.

[22]  Lijun Sun,et al.  Role of Sterol Regulatory Element-binding Protein 1 in Regulation of Renal Lipid Metabolism and Glomerulosclerosis in Diabetes Mellitus* , 2002, The Journal of Biological Chemistry.

[23]  R. Hammer,et al.  Diminished Hepatic Response to Fasting/Refeeding and Liver X Receptor Agonists in Mice with Selective Deficiency of Sterol Regulatory Element-binding Protein-1c* , 2002, The Journal of Biological Chemistry.

[24]  A. Casellas,et al.  Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance. , 2002, Diabetes.

[25]  S. Bigler,et al.  Functional and structural changes in the kidney in the early stages of obesity. , 2001, Journal of the American Society of Nephrology : JASN.

[26]  R. Tilton,et al.  Antibodies against Vascular Endothelial Growth Factor Improve Early Renal Dysfunction in Experimental Diabetes Materials and Methods Laboratory Animals , 2022 .

[27]  L. Groop,et al.  Cardiovascular morbidity and mortality associated with the metabolic syndrome. , 2001, Diabetes care.

[28]  M. Cooper,et al.  Potential influence of lipids in diabetic nephropathy: insights from experimental data and clinical studies. , 2000, Diabetes & metabolism.

[29]  H. Gin,et al.  Lipids, protein intake, and diabetic nephropathy. , 2000, Diabetes & metabolism.

[30]  I. Shimomura,et al.  Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[31]  F. Lammert,et al.  Phenotypic characterization of lith genes that determine susceptibility to cholesterol cholelithiasis in inbred mice. Pathophysiology Of biliary lipid secretion. , 1999, Journal of lipid research.

[32]  M. Rosenfeld,et al.  Initiation of Hyperinsulinemia and Hyperleptinemia is Diet Dependent in C57BL/6 Mice , 1999, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[33]  P. Parekh,et al.  Reversal of diet-induced obesity and diabetes in C57BL/6J mice. , 1998, Metabolism: clinical and experimental.

[34]  J. Bonventre,et al.  Ischemia and Reperfusion Enhance ATF-2 and c-Jun Binding to cAMP Response Elements and to an AP-1 Binding Site from the c-jun Promoter (*) , 1995, The Journal of Biological Chemistry.

[35]  H. Schnaper,et al.  ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade. , 1995, Kidney international.

[36]  A. Kissebah,et al.  Relation of Body Fat Distribution to Metabolic Complications of Obesity , 1982 .

[37]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[38]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[39]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[40]  R. Virchow,et al.  Cellular Pathology, as Based upon Physiological and Pathological Histology , 1860, Nutrition reviews.

[41]  B. Kasiske,et al.  Effect of lipid reduction on the progression of renal disease: a meta-analysis. , 2001, Kidney international.

[42]  V. Kamanna,et al.  Role of atherogenic lipoproteins in cytokine-mediated renovascular injury. , 1996, Mineral and electrolyte metabolism.

[43]  B. Rovin,et al.  LDL stimulates mesangial fibronectin production and chemoattractant expression. , 1993, Kidney international.

[44]  P. Kimmelstiel,et al.  Intercapillary Lesions in the Glomeruli of the Kidney. , 1936, The American journal of pathology.